These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3038985)

  • 1. Dieting and weight loss in volunteers increases the number of alpha 2-adrenoceptors and 5-HT receptors on blood platelets without effect on [3H]imipramine binding.
    Goodwin GM; Fraser S; Stump K; Fairburn CG; Elliott JM; Cowen PJ
    J Affect Disord; 1987; 12(3):267-74. PubMed ID: 3038985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased platelet 3H-imipramine binding sites in classical migraine.
    Geaney DP; Rutterford MG; Elliott JM; Schächter M; Peet KM; Grahame-Smith DG
    J Neurol Neurosurg Psychiatry; 1984 Jul; 47(7):720-3. PubMed ID: 6086845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients.
    Arora RC; Meltzer HY
    Life Sci; 1989; 44(11):725-34. PubMed ID: 2927243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of yohimbine and imipramine to platelets in depressive illness.
    Braddock L; Cowen PJ; Elliott JM; Fraser S; Stump K
    Psychol Med; 1986 Nov; 16(4):765-73. PubMed ID: 3029789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of [125I]iodolysergic acid diethylamide binding in human frontal cortex and platelet tissue.
    Elliott JM; Kent A
    J Neurochem; 1989 Jul; 53(1):191-6. PubMed ID: 2723656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet binding studies in panic disorder.
    Nutt DJ; Fraser S
    J Affect Disord; 1987; 12(1):7-11. PubMed ID: 3033042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment.
    Cowen PJ; Charig EM; Fraser S; Elliott JM
    J Affect Disord; 1987; 13(1):45-50. PubMed ID: 2959699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desipramine treatment in normal subjects. Effects on neuroendocrine responses to tryptophan and on platelet serotonin (5-HT)-related receptors.
    Cowen PJ; Geaney DP; Schächter M; Green AR; Elliott JM
    Arch Gen Psychiatry; 1986 Jan; 43(1):61-7. PubMed ID: 3942474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]Dihydroergocryptine binding to alpha-adrenergic receptors of human platelets. A reassessment using the selective radioligands [3H]prazosin, [3H]yohimbine, and [3H]rauwolscine.
    Motulsky HJ; Insel PA
    Biochem Pharmacol; 1982 Aug; 31(16):2591-7. PubMed ID: 6291538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
    Spigset O; Allard P; Mjörndal T
    Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet [3H]imipramine and alpha 2-adrenoceptor binding in normal subjects during desipramine administration and withdrawal.
    Healy DT; Paykel ES; Whitehouse AM; White W; Wilton-Cox H; Johnson AL; Theodorou AE; Lawrence K; Horton RW
    Neuropsychopharmacology; 1991 Feb; 4(2):117-24. PubMed ID: 1851012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors.
    Glue PW; Cowen PJ; Nutt DJ; Kolakowska T; Grahame-Smith DG
    Psychopharmacology (Berl); 1986; 90(3):398-402. PubMed ID: 3097730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
    Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
    J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine.
    Poirier MF; Galzin AM; Loo H; Pimoule C; Segonzac A; Benkelfat C; Sechter D; Zarifian E; Schoemaker H; Langer SZ
    Biol Psychiatry; 1987 Mar; 22(3):287-302. PubMed ID: 3028514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine (5-HT)-induced shape change in human platelets determined by computerized data acquisition: correlation with [125I]-iodoLSD binding at 5-HT2 receptors.
    Brazell C; McClue SJ; Preston GC; King B; Stahl SM
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):17-24. PubMed ID: 1772986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects.
    Kamal LA; Raisman R; Meyer P; Langer SZ
    Life Sci; 1984 May; 34(21):2083-8. PubMed ID: 6328154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the binding to platelets of [3H]imipramine and [3H]yohimbine in normal subjects taking amitriptyline.
    Braddock LE; Cowen PJ; Elliott JM; Fraser S; Stump K
    Neuropharmacology; 1984 Feb; 23(2B):285-6. PubMed ID: 6709132
    [No Abstract]   [Full Text] [Related]  

  • 18. Alteration of platelet alpha 2-adrenoceptors in human hypertension.
    Continsouza-Blanc D; Elghozi JL; Dausse JP
    J Hypertens Suppl; 1984 Dec; 2(3):S155-7. PubMed ID: 6100735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine.
    Lawrence KM; Falkowski J; Jacobson RR; Horton RW
    Psychopharmacology (Berl); 1993; 110(1-2):235-9. PubMed ID: 7870891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
    Lanza F; Cazenave JP
    Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.